Clinical studies recruiting near Lexington

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Methadone for Post-operative Spine Surgery
Phase 4 · University of Kentucky · Brandon Knopp · NCT07517679 KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · University of Kentucky Markey Cancer Center ( Site 0019) · Merck Sharp & Dohme LLC · NCT04165070 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · University of Kentucky Chandler Medical Center · Eli Lilly and Company · NCT07218380 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10080, Lexington, KY · Colorado Prevention Center · NCT06024746 K23- Physical Self Regulation vs Placebo
NA · University of Kentucky · Ian Boggero, PhD · NCT06357702 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · University of Kentucky Chandler Medical Center · Bristol-Myers Squibb · NCT07106762 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · University of Kentucky/Markey Cancer Center · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · University of Kentucky/Markey Cancer Center · National Cancer Institute (NCI) · NCT05099003 REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for
NA · University of Kentucky · Duke University · NCT05218083 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · University of Kentucky/Markey Cancer Center · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · AMR Clinical - Lexington · Kallyope Inc. · NCT07674654 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Baptist Health Lexington /ID# 272211 · AbbVie · NCT06682988 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · University of Kentucky/Markey Cancer Center · NRG Oncology · NCT05624996 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · University of Kentucky HealthCare (UKHC) Kentucky Clinic · H. Lundbeck A/S · NCT05897320 A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Phase 1 · Virginia Cancer Specialists · TORL Biotherapeutics, LLC · NCT06005740 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0132 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · University of Kentucky/Markey Cancer Center · National Cancer Institute (NCI) · NCT05691478 Time-restricted Eating for Patients With Type 2 Diabetes
NA · University of Kentucky Barnstable Brown Diabetes Center · Justin (Matt) Thomas · NCT07318207 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · University of Kentucky Markey Cancer Center · Clasp Therapeutics, Inc. · NCT06778863 Auditory Biofeedback Gait Training Individuals With Chronic Ankle Instability
NA · University of Kentucky · Danielle Torp · NCT06868316 Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · University of Kentucky/Markey Cancer Center · National Cancer Institute (NCI) · NCT04172532 Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astr
Phase 1 · University of Kentucky/Markey Cancer Center · National Cancer Institute (NCI) · NCT06860594 Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Can
Phase 2 · University of Kentucky/Markey Cancer Center · National Cancer Institute (NCI) · NCT05691465 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · CommonSpirit Saint Joseph Hospital - Lexington · Alliance for Clinical Trials in Oncology · NCT07091617 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · University of Kentucky · Novartis Pharmaceuticals · NCT06581198 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Baptist Health Lexington · Eli Lilly and Company · NCT06890598 Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Kentucky Children's Hospital · Children's Hospital of Philadelphia · NCT02708134 Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Chang
Phase 1 · University of Kentucky/Markey Cancer Center · National Cancer Institute (NCI) · NCT05372614 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · University of Kentucky · Regeneron Pharmaceuticals · NCT06091865

Look up another city

Look up another condition